Tarsus Pharmaceuticals (TARS) Other Non-Current Liabilities (2019 - 2026)
Tarsus Pharmaceuticals (TARS) posted Other Non-Current Liabilities of $15.9 million for Q2 2026, down 1.1% from the prior quarter.
Powered by 
Analysis
Tarsus Pharmaceuticals (TARS) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends
At the end of FY2025, Tarsus Pharmaceuticals' Other Non-Current Liabilities came in at $10.6 million.
- Annual Other Non-Current Liabilities shows a five-year compound annual growth rate of 77.3% (FY2020 to FY2025).
- In prior years, Tarsus Pharmaceuticals' Other Non-Current Liabilities was $1.75 million in FY2023, $100,000 in FY2022 (-85.7%) and $699,000 in FY2021 (+15.5%).
- Quarterly Other Non-Current Liabilities has run from a low of $40,000 in Q1 2023 to a high of $16.08 million in Q1 2026 over five years.
- The strongest year-over-year quarter for Other Non-Current Liabilities in the past five years was Q3 2023, with growth of 718.7%; the weakest was Q1 2023, with a decline of 91.9%.
- According to Business Quant data, Other Non-Current Liabilities for the three prior quarters was $16.08 million (Q1 2026), $10.6 million (Q4 2025) and $10.15 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Tarsus Pharmaceuticals | 3.40 Bn | 2.35 Bn | 161.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.90 Mn |
| Mar 31, 2026 | 16.08 Mn |
| Dec 31, 2025 | 10.60 Mn |
| Sep 30, 2025 | 10.15 Mn |
| Sep 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | 1.45 Mn |
| Mar 31, 2024 | 1.61 Mn |
| Dec 31, 2023 | 1.75 Mn |
| Sep 30, 2023 | 1.71 Mn |
| Jun 30, 2023 | 1.83 Mn |
| Mar 31, 2023 | 40,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Sep 30, 2022 | 209,000.00 |
| Jun 30, 2022 | 343,000.00 |
| Mar 31, 2022 | 496,000.00 |
| Dec 31, 2021 | 699,000.00 |
| Sep 30, 2021 | 905,000.00 |
| Jun 30, 2021 | 524,000.00 |
| Mar 31, 2021 | 604,000.00 |
| Dec 31, 2020 | 605,000.00 |
API Access
Tarsus Pharmaceuticals Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=TARS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "TARS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=TARS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();